10/18/2021I-Mab Granted IND Approval for P2 Trial of Efineptakin Alfa in Combo w...

10/18/2021Innovent's P3 Study of Sintilimab for EGFR-Mutated Nonsquamous NSCLC ...

10/18/2021Forbes: What Can We Learn From the Pharma Manufacturers Leaving China?

10/15/2021PharmaDJ: September Fundraising Puts Cell Therapy and Immuno-Oncology ...

10/15/2021CDE Issues the List of Reference Formulations for GQCE Studies (45th B...

10/15/2021China Issues the Action Plan for Tumor Diagnosis and Treatment Quality...

10/15/2021CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...

10/15/2021State Council Issues the Implementation Opinion for Promotion of Sanmi...

10/15/2021Silence Therapeutics Inks Collaboration Deal with Hansoh Pharma

10/15/2021Gan & Lee Concludes Phase 3 Studies of Biosimilar Insulin Glargine (G...

10/15/2021Harbour Biomed Begins P3 Study of Hanall's HL161 (batoclimab)

10/15/2021Bio-Thera Solutions Expands Partnership with Pharmapark in Russia and ...

10/15/2021Akeso Advances Phase II Trial of IL-4R mAb (AK120) for Atopic Dermatit...

10/15/2021Shanghai-based Abbisko Makes $200M+ Hong Kong Debut

10/15/2021Adocia's Partner Tonghua Dongbao Cleared to Start Ultra-Rapid Insulin ...

10/15/2021Recent Executive Moves

10/15/2021Takeda Secures New Indication for Takecab as Maintenance Therapy of Re...

10/14/2021CDE Issues the Technical Guidance for Clinical Research of Anti-HIV Dr...

10/14/2021NHC Issues Five New Standards for Pharmacy Service in Medical Institu...

10/14/2021Dr. Reddy's Becomes the First Indian Company to Launch An Anticancer i...

10/14/2021China's Health Insurance Premiums to Top CNY 1 Trillion in 2021

10/14/2021BMS Moves to Terminate China Abraxane Deal with BeiGene amid Disputes

10/14/2021Luye Pharma's Marketing Application for Biosimilar Denosumab Injection...

10/13/2021CDE Solicits Comments on Draft Technical Guidance for Clinical Researc...

10/13/2021Upcoming Event: Global Biopharma Innovation Pioneer China Summit 2021

10/13/2021D&D and Salubris Enter Licensing Deal for Obesity Drug DD01 in China

10/13/2021Geneseeq, Zai Lab Enter Strategic Cancer R&D Alliance

10/13/2021CDE Approves IND for Combination of Asieris' APL-1202 and BeiGene's Ti...

10/13/2021China's CDMO Market Growing Rapidly Despite Talent Shortage, Says Lonz...

10/13/2021PharmExec: Improving Readiness for VBP in China

Page:110/719 Total number of articles:21546: [First][<<] [108] [109] [110] [111] [112] [>>] [End]